Kim Kamdar

Kim Kamdar

Presidente en SERA PROGNOSTICS, INC. .

Fortuna: 74 559 $ al 30/04/2024

56 años
Health Technology
Finance
Health Services

Perfil

Kim Puloma Kamdar founded Truvian Sciences, Inc. in 2015, where she is working as Chairman.
Dr. Kamdar also founded Aryzun Pharmaceuticals and Seraphina Therapeutics, Inc., where she is working as Chairman.
Dr. Kamdar also currently works at Sera Prognostics, Inc., as Chairman from 2023, ROX Medical, Inc., as Director, One Palmer Square Associates VII LLC, as Director, The Hastings Center, as Director, Epic Sciences, Inc., as Director, Connect Foundation, as Director, SalveoDx, as Director, Evofem Biosciences, Inc., as Independent Director, Singular Genomics Systems, Inc., as Independent Director from 2017, Alume Biosciences, Inc., as Director from 2020, Epitel, Inc., as Director & Partner, Access Youth Academy, as Director, Pleno, Inc., as Director, Domain Associates LLC, as Partner from 2011, One Palmer Square Associates VIII LLC, as Managing Member, Domain LLC, as Partner from 2011, Adjuvant Capital LP, as Advisory Partner, and Medical Excellence Capital LLC, as Managing Partner from 2021.
Dr. Kamdar also formerly worked at Aspen Neuroscience, Inc., as Chairman & Chief Executive Officer, Obalon Therapeutics, Inc., as Chairman from 2020 to 2021, Corthera, Inc., as Director, Novartis International AG, as Research Director, Achaogen, Inc., as Director, BiPar Sciences, Inc., as Director, Adastra Pharmaceuticals, Inc., as Director, Syndax Pharmaceuticals, Inc., as Independent Director from 2006 to 2017, Omniome LLC, as Director, Sonexa Therapeutics, Inc., as Director, Nuon Therapeutics, Inc., as Director, Altair Therapeutics, Inc., as Director, Neothetics, Inc., as Director from 2011 to 2014, Ariosa Diagnostics, Inc., as Director from 2010 to 2015, San Diego Venture Group, as Director, MPM BioImpact, Inc, as Principal in 2004, Torrey Mesa Research Institute, as Program Leader, and Bill & Melinda Gates Foundation, as Advisor.
Dr. Kamdar received her doctorate degree in 1995 from Emory University and undergraduate degree in 1988 from Northwestern University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
31/03/2024 6 629 ( 0.02% ) 68 544 $ 30/04/2024
29/02/2024 15 000 ( 0.02% ) 6 015 $ 30/04/2024

Cargos activos de Kim Kamdar

EmpresasCargoInicio
SERA PROGNOSTICS, INC. Presidente 08/06/2023
SINGULAR GENOMICS SYSTEMS, INC. Director/Miembro de la Junta 01/05/2017
EVOFEM BIOSCIENCES, INC. Director/Miembro de la Junta 01/01/2018
Inversor de Capital Privado 01/01/2005
Connect Foundation Director/Miembro de la Junta -
SalveoDx Director/Miembro de la Junta -
Fundador 01/01/2015
One Palmer Square Associates VII LLC Director/Miembro de la Junta -
Consultor / Asesor -
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ -
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
Todos los cargos activos de Kim Kamdar

Antiguos cargos conocidos de Kim Kamdar.

EmpresasCargoFin
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Kim Kamdar.

Formación de Kim Kamdar.

Emory University Doctorate Degree
Northwestern University Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Kim Kamdar.

Relaciones

100 +

Relaciones de 1er grado

41

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas4
SYNDAX PHARMACEUTICALS, INC.

Health Technology

SERA PROGNOSTICS, INC.

Health Services

EVOFEM BIOSCIENCES, INC.

Health Technology

SINGULAR GENOMICS SYSTEMS, INC.

Health Technology

Empresas privadas35

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Finance

Health Technology

One Palmer Square Associates VII LLC

Health Technology

Health Technology

Finance

Distribution Services

Health Technology

One Palmer Square Associates VIII LLC

Aryzun Pharmaceuticals

Health Services

The Hastings Center

Health Technology

Finance

Connect Foundation

SalveoDx

Health Services

Health Services

Commercial Services

Finance

Technology Services

Commercial Services

Consumer Services

Health Services

Technology Services

Finance

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA